Optimal Duration of Daily Antituberculosis Therapy before Switching to DOTS Intermittent Therapy to Reduce Mortality in HIV Infected Patients: A Duration-Response Analysis Using Restricted Cubic Splines

<div>Mortality risk (adjusted hazard ratio and 95% confidence interval) of HIV infected patients with tuberculosis by duration daily treatment during the first two months of antituberculosis therapy (ATT).</div>

International Scholarly Research Notices

fig3

Figure 3

Figure 3: Optimal Duration of Daily Antituberculosis Therapy before Switching to DOTS Intermittent Therapy to Reduce Mortality in HIV Infected Patients: A Duration-Response Analysis Using Restricted Cubic Splines 

Figure 3 | Optimal Duration of Daily Antituberculosis Therapy before Switching to DOTS Intermittent Therapy to Reduce Mortality in HIV Infected Patients: A Duration-Response Analysis Using Restricted Cubic Splines 